Integrating the transcriptome and proteome reveals two prognostic biomarkers for breast cancer, particularly for the estrogen receptor positive subset.
IJMS, Free Full-Text
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes
Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
Integrating SWATH-MS Proteomics and Transcriptome Analysis Identifies CHI3L1 as a Plasma Biomarker for Early Gastric Cancer: Molecular Therapy - Oncolytics
Full article: Identification of significant genes and therapeutic agents for breast cancer by integrated genomics
Frontiers Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer
Revolutionary Cancer Research Breakthroughs
Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus
Proteomes, Free Full-Text
Frontiers Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
PDF) Survival analysis in breast cancer using proteomic data from four independent datasets
Proteomes, Free Full-Text
Proteomics and its applications in breast cancer.
Frontiers Integrative Analysis of Membrane Proteome and MicroRNA Reveals Novel Lung Cancer Metastasis Biomarkers
Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses - ScienceDirect